Presynaptic imidazoline receptors mediate inhibition of noradrenaline release from sympathetic nerves in rat blood vessels

Summary— In rat vena cava and aorta preincubated with [3H]noradrenaline the involvement of imidazoline receptors in modulation of [3H]noradrenaline release from sympathetic nerves was investigated. In the vena cava, the guanidine 1,3‐di(2‐tolyl)guanidine (DTG) inhibited the electrically evoked [3H]noradrenaline release; the inhibitory effect was more pronounced in the presence than in the absence of the α2‐adrenoceptor antagonist rauwolscine. The concentration‐response curves of BDF 6143 [4‐chloro‐2‐(2‐imidazolin‐2‐ylamino)‐isoindoline], and idazoxan for their facilitatory effect on electrically evoked [3H]noradrenaline release was bell‐shaped; in the presence of rauwolscine, BDF 6143 inhibited the evoked [3H)noradrenaline release, whereas idazoxan did not. After blockade of α2‐autoreceptors by rauwolscine, the electrically evoked [3H]noradrenaline release from vena cava was inhibited not only by DTG and BDF 6143 but also by aganodine, clonidine and cirazoline; the rank order of potency of most of the drugs was similar to that found at the presynaptic imidazoline receptors in the rabbit aorta and pulmonary artery as well as in human atrial appendages. In the presence of rauwolscine, clonidine‐induced inhibition of electrically evoked [3H]noradrenaline release was counteracted by 1 μM of the selective CB1 receptor antagonist SR141716A (N‐[piperidin‐1‐yl]‐5‐[4‐chlorophenyl]‐1‐[2,4‐dichlorophenyl]‐4‐methyl‐1H‐pyrazole‐3‐carboxamide). In the aorta, BDF 6143 and cirazoline did not modify [3H]noradrenaline release in the absence of α2‐adrenoceptor blockade; in the presence of rauwolscine, the electrically evoked [3H]noradrenaline release from aorta was inhibited by BDF 6143, cirazoline, aganodine and Clonidine with a rank order of potency similar to that in the vena cava. SR141716A 1 μM antagonized the inhibitory effect of BDF 6143 and Clonidine (in the presence of rauwolscine). In conclusion, noradrenaline release in rat vena cava and aorta is inhibited via presynaptic imidazoline receptors which appear to be related to those previously characterized in rabbit and human cardiovascular tissue.

[1]  G. Molderings,et al.  Presynaptic imidazoline receptors and non‐adrenoceptor[3H]‐idazoxan binding sites in human cardiovascular tissues , 1997, British journal of pharmacology.

[2]  R. Martı́n-Ruiz,et al.  Agmatine does not have activity at α 2-adrenoceptors which modulate the firing rate of locus coeruleus neurones: an electrophysiological study in rat , 1996, Neuroscience Letters.

[3]  P. Soubrié,et al.  Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. , 1996, Life sciences.

[4]  K. Fink,et al.  α2‐Adrenoceptor‐Independent Inhibition by Imidazolines and Guanidines of Noradrenaline Release from Peripheral, but Not Central Noradrenergic Neurons , 1995, Annals of the New York Academy of Sciences.

[5]  D. Kendall,et al.  Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with α2‐adrenoceptor binding sites , 1995, British journal of pharmacology.

[6]  P. Soubrié,et al.  Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. , 1995, Life sciences.

[7]  P. Ernsberger,et al.  Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. , 1995, The Journal of pharmacology and experimental therapeutics.

[8]  D. Reis,et al.  Agmatine: an endogenous clonidine-displacing substance in the brain. , 1994, Science.

[9]  P. Ernsberger,et al.  A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors , 1992 .

[10]  C. Raper ADRENOCEPTOR CLASSIFICATION , 1987, Clinical and experimental pharmacology & physiology.

[11]  K. Starke Presynaptic α-autoreceptors , 1987 .

[12]  K. Starke Presynaptic alpha-autoreceptors. , 1987, Reviews of physiology, biochemistry and pharmacology.

[13]  M. Sonders,et al.  1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Starke α-Adrenoceptor subclassification , 1981 .

[15]  K. Starke Alpha-adrenoceptor subclassification. , 1981, Reviews of physiology, biochemistry and pharmacology.

[16]  R. Furchgott The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory , 1972 .